Clinical Trial Update: A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186 [Phase 1]

View source ↗

Summary

A Phase 1 study of AZD0186 in Type 2 diabetes mellitus sponsored by AstraZeneca has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD0186

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 1 | Status: TERMINATED